A peek into the drug development scenario of endometriosis – A systematic review

Luxitaa Goenka, Melvin George, Maitrayee Sen
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2017 · vol. 90 , pp. 575–585 · doi:10.1016/j.biopha.2017.03.092 · PMID:28407578 · W2606572014
review OA: closed CC0 ⤵ 24 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This systematic review examines the current landscape of drug development for endometriosis, identifying key therapeutic targets and emerging treatment strategies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Pharmaceutical Preparations Animals Drug Discovery Drug Discovery Endometriosis Female Humans Pharmaceutical Preparations

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (89)

Cited by (24)

Source provenance

europepmc
last seen: 2026-06-16T06:07:01.518242+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:31.759405+00:00
License: CC0 · commercial use OK